Tue.Jun 04, 2024

article thumbnail

A new discovery about carbon dioxide is challenging decades-old ventilation doctrine

STAT

Carbon dioxide monitors have been around for decades. But in 2020, they became, almost overnight, a hot commodity. All of a sudden, people wanted them to help assess the safety of indoor spaces — to gauge the likelihood of breathing in coronavirus-laced particles that until very recently had been in someone else’s lungs. No sensor can monitor how many infectious aerosols are swirling around us in real time.

364
364
article thumbnail

What’s in a drug name? More than you might think.

PharmaVoice

From regulatory restrictions to evocative letter strings, branded drug naming is both an art and a science. We break down the process.

148
148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Tracking the FDA advisory panel on MDMA therapy for PTSD

STAT

Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for MDMA-assisted psychotherapy to treat post-traumatic stress disorder. The discussion will start at 8:30 a.m. ET and run until about 5:30 p.m. ( here’s an agenda ). We published an in-depth story on Friday about what to expect today , but here are the basics: MDMA is the first Schedule I psychedelic to be considered by

363
363
article thumbnail

FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns

BioPharma Dive

A group of independent experts wasn't convinced by clinical trial data from company Lykos Therapeutics, which is seeking FDA approval of MDMA-assisted treatment for post-traumatic stress disorder.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Medicare Advantage plan’s quality ratings were incorrectly calculated by government, judge rules

STAT

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday. The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees.

article thumbnail

Key takeaways from ViVE: AI, security concerns, and industry transactions take centre stage

pharmaphorum

ViVE conference highlights the key takeaways on artificial intelligence, cybersecurity concerns, and industry transactions. Stay updated on the latest trends and partnerships shaping these fields.

121
121

More Trending

article thumbnail

Bayer taps Samsung wearables for menopause sleep study

pharmaphorum

Sleep disturbances are one of the most common and disruptive symptoms in menopausal women, but not enough is known about the causes, and current sleep aids are often ineffective. To plug that gap, Germany’s Bayer has joined forces with electronics group Samsung to carry out an observational study on sleep disturbances during menopause (SDM), tapping into the South Korean company’s position as one of the world's largest producers of consumer electronics.

111
111
article thumbnail

Opinion: Outdated Medicare rules prevent some dementia patients from getting the medications they need

STAT

Memory loss is the most obvious symptom of Alzheimer’s disease. But for the more than 6.5 million Americans who suffer from Alzheimer’s disease — and the people who support them — memory lapses are often the least of their problems. Many people with Alzheimer’s or other forms of dementia also experience mood and behavior symptoms ranging from anxiety and depression to violent outbursts and psychosis.

351
351
article thumbnail

Abbott’s OTC glucose monitor ‘will grow the market’

pharmaphorum

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and analysts think uptake by patients is now poised to take off.

114
114
article thumbnail

STAT+: U.S. drug shortages have reached a decade high and are lasting longer, too

STAT

Amid rising concern over prescription drug shortages, a new report finds that the number of shortages has increased over the past decade, most are lasting longer than ever before, and the problem is affecting medicines used to treat a wide range of maladies. Specifically, the average shortage lasted for more than three years in 2023 compared to about two years in 2020, and 27 of the 125 drugs in short supply were not available for more than five years.

333
333
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

ASCO 2024 - Mohit Manrao

pharmaphorum

Get insights into the exclusive interview with Mohit Manrao, AstraZeneca SVP and Head of Oncology. Explore the highlights of the conversation and ASCO 2024 here.

114
114
article thumbnail

5 takeaways from STAT’s look at unwanted supplies and surprise bills from device maker Zynex Medical

STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need. STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees.

299
299
article thumbnail

ASCO: Moderna may file melanoma vaccine on phase 2b data

pharmaphorum

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme.

Vaccines 112
article thumbnail

STAT+: Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug

STAT

CHICAGO — Something is off about the way Novartis is talking about pelabresib, its newly acquired and costly treatment for myelofibrosis. I suspect the Swiss pharma giant’s previously stated plan to submit a marketing application to the Food and Drug Administration this year has been blocked. I’m not just speculating wildly. It’s looking increasingly likely that the $3 billion purchase of MorphoSys to acquire pelabresib — a deal pushed hard by top Novartis exec

280
280
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Exploring the Potential of mRNA (BIO 2024)

PharmaTech

Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.

115
115
article thumbnail

ASCO Takeaways: Winners, snoozers, the China question, and the art of cancer care

STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. We’ll resume for ASCO 2025.  Well, dear readers. Our ASCO reporting, including this newsletter, has come to the end. Read below for takeaway thoughts from Matt, Adam, and Angus.

279
279
article thumbnail

Climate change may aggravate multiple sclerosis

Pharmaceutical Technology

A June 2024 literature review has revealed that climate change has the potential to intensify MS symptoms, as well as the incidence, prevalence, and severity of other major neurological disorders.

98
article thumbnail

STAT+: Pharmalittle: We’re reading about an FDA meeting on MDMA, a new obesity pill, and more

STAT

Top of the morning to you, and a fine one it is. There is nothing like being greeted with clear blue skies and cool breezes upon waking up today on the Pharmalot campus. Birds are chirping, squirrels are scavenging, official mascots are barking. And we are similarly engaged in early-in-the-day rituals of our own — firing up the trusty coffee kettle for another cup of stimulation.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Eli Lilly selects new EVP of Global Quality

European Pharmaceutical Review

Eli Lilly and Company has announced its new Executive Vice President of Global Quality. This news follows a statement by the firm at the start of this year declaring the retirement of its long-serving current EVP. A new start at Eli Lilly Melissa Seymour will begin her new role as EVP at Eli Lilly on 22 July 2024. As part of this position, she will also serve as a member of the company’s Executive Committee.

article thumbnail

Operation Warp Speed but for rare disease

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Today, FDA advisers are convening to discuss Lykos Therapeutics’ MDMA-assisted psychotherapy for people with PTSD. It’s a critical meeting — MDMA could be the first Schedule I psychedelic to be deemed to have a medical use.

article thumbnail

Advancing innovation in life sciences R&D and Quality: Towards a single source of truth

pharmaphorum

Discover the latest advancements in life sciences R&D and quality at the Veeva R&D Quality Summit at the Marriott Auditorium Hotel in Madrid. Join industry leaders as they discuss the importance of a single source of truth.

110
110
article thumbnail

GSK shares fall 9% in wake of Zantac court ruling

Pharmaceutical Technology

Monday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE) following a Delaware judge’s ruling on 31 May that over 72,000 lawsuits over discontinued heartburn drug Zantac, known generically as ranitidine, could go ahead.

97
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

PharmaLytica 2024: charting India’s pharma’s path to USD 130 billion by 2030 from the powerhouse hub of Hyderabad

Express Pharma

The premier expo opened its door to over 200 exhibitors showcasing more than 1000 brands offering insights into Machinery & Packaging, Lab Analytical & Cleanroom, and Pharma Ingredients segments The 10th edition of PharmaLytica, organised by Informa Markets in India, commenced at HITEX, Hyderabad. It focused on redefining the pharmaceutical industry in the post-COVID era.

Packaging 101
article thumbnail

Medicine shortage warnings triple in last two years

The Pharmacist

More than three times as many serious shortage protocols (SSPs) were issued in 2022-24 than in 2020-22, according to analysis by the National Pharmacy Association (NPA). And in a three-day period last month, the same number of SSPs were issued as those issued during the whole of 2020. The NPA warned that shortages were leading […] The post Medicine shortage warnings triple in last two years appeared first on The Pharmacist.

99
article thumbnail

The IMA Group at ACHEMA 2024 : All-In-One solutions for the pharmaceutical sector

European Pharmaceutical Review

In an area covering almost 1,400m 2 , the Pharmaceutical Divisions of IMA Group and its specialists are glad to introduce IMA Pharma, the All-In-One supplier specialised in the design and manufacture of innovative machines and complete lines for the processing and packaging of pharmaceutical and nutraceutical products, medical devices assembling, as well as projects concerning digitalisation , sustainability, and customer service solutions.

article thumbnail

Pharma funding sees volatile shifts in May 2024

Express Pharma

Despite a 69.2 per cent month-over-month drop, funding soars nearly 380% YoY, with late-stage investments dominating the scene As per the data presented by Tracxn.com, funding in the pharmaceutical sectors dropped 69.2 per cent to $261 million in May 2024 from $846 million in April 2024. However, this figure represented a 379.8 per cent increase compared to the $54.4 million raised in May 2023.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

NIH AI tool predicts cancer patients’ immunotherapy outcomes

Pharmaceutical Technology

Scientists at the NIH have introduced an AI tool to predict the response to immune checkpoint inhibitors for cancer patients.

Immunity 112
article thumbnail

Exclusive interview: Diane Lacroix talks innovations in clinical data management

Outsourcing Pharma

In celebration of Clinical Trials Day last month, OSP sat down with Diane Lacroix, vice president of clinical data management at eClinical Solutions, to delve into the latest advancements and future directions in clinical trials.

95
article thumbnail

ASCO 2024: Alligator shares positive data for pancreatic cancer drug

Pharmaceutical Technology

Alligator Bioscience’s CEO says that its pancreatic cancer drug may mark a meaningful improvement on current treatment standards.

109
109
article thumbnail

BREAKING: NPA plans 'day of action' to save community pharmacy

The Pharmacist

The National Pharmacy Association (NPA) has announced a 'day of action' on 20 June which could see some pharmacies 'turning off the lights' for two hours. NPA chief executive Paul Rees announced the association's 'One Day to Save Our Pharmacies' initiative this morning and said it hoped to 'show the politicians there's a state of […] The post BREAKING: NPA plans 'day of action' to save community pharmacy appeared first on The Pharmacist.

article thumbnail

Nidlegy Marketing Authorization Application Submitted to EMA

Express Pharma

First marketing authorisation submission for Nidlegy for the treatment of locally advanced, fully resectable melanoma in the neoadjuvant setting Philogen and Sun Pharma, announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for the approval of Nidlegy, an investigational treatment for neoadjuvant (i.e., prior to surgery) locally advanced fully resectable melanoma.